Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5Δ32 allele

被引:45
作者
Gray, L
Churchill, MJ
Keane, N
Sterjovski, J
Ellett, AM
Purcell, DFJ
Poumbourios, P
Kol, C
Wang, B
Saksena, NK
Wesselingh, SL
Price, P
French, M
Gabuzda, D
Gorry, PR
机构
[1] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3001, Australia
[2] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia
[3] Royal Perth Hosp, Dept Clin Immunol & Biochem Genet, Perth, WA, Australia
[4] Univ Western Australia, Sch Surg & Pathol, Perth, WA 6009, Australia
[5] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia
[6] Westmead Millennium Inst, Westmead, NSW, Australia
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
关键词
D O I
10.1128/JVI.80.7.3684-3691.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We characterized human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins (Env) isolated from two HIV-1-infected CCR5 Delta 32 homozygotes. Envs from both subjects used CCR5 and CXCR4 for entry into transfected cells. Most R5X4 Envs were lymphocyte-tropic and used CXCR4 exclusively for entry into peripheral blood mononuclear cells (PBMC), but a subset was dually lymphocyte- and macrophage-tropic and used either CCR5 or CXCR4 for entry into PBMC and monocyte-derived macrophages. The persistence of CCR5-using HIV-1 in two CCR5 Delta 32 homozygotes suggests the conserved CCR5 binding domain of Env is highly stable and provides new mechanistic insights important for HIV-1 transmission and persistence.
引用
收藏
页码:3684 / 3691
页数:8
相关论文
共 54 条
[1]   A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity [J].
Baba, M ;
Nishimura, O ;
Kanzaki, N ;
Okamoto, M ;
Sawada, H ;
Iizawa, Y ;
Shiraishi, M ;
Aramaki, Y ;
Okonogi, K ;
Ogawa, Y ;
Meguro, K ;
Fujino, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5698-5703
[2]   Homozygous Delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient [J].
Balotta, C ;
Bagnarelli, P ;
Violin, M ;
Ridolfo, AL ;
Zhou, D ;
Berlusconi, A ;
Corvasce, S ;
Corbellino, M ;
Clementi, M ;
Clerici, M ;
Moroni, M ;
Galli, M .
AIDS, 1997, 11 (10) :F67-F71
[3]   HIV-1 infection in an individual homozygous for the CCR5 deletion allele [J].
Biti, R ;
French, RF ;
Young, J ;
Bennetts, B ;
Stewart, G ;
Liang, T .
NATURE MEDICINE, 1997, 3 (03) :252-253
[4]   The orphan seven-transmembrane receptor Apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1 [J].
Choe, H ;
Farzan, M ;
Konkel, M ;
Martin, K ;
Sun, Y ;
Marcon, L ;
Cayabyab, M ;
Berman, M ;
Dorf, ME ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
JOURNAL OF VIROLOGY, 1998, 72 (07) :6113-6118
[5]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[6]   Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J].
Dean, M ;
Carrington, M ;
Winkler, C ;
Huttley, GA ;
Smith, MW ;
Allikmets, R ;
Goedert, JJ ;
Buchbinder, SP ;
Vittinghoff, E ;
Gomperts, E ;
Donfield, S ;
Vlahov, D ;
Kaslow, R ;
Saah, A ;
Rinaldo, C ;
Detels, R ;
OBrien, SJ .
SCIENCE, 1996, 273 (5283) :1856-1862
[7]   Expression cloning of new receptors used by simian and human immunodeficiency viruses [J].
Deng, HK ;
Unutmaz, D ;
KewalRamani, VN ;
Littman, DR .
NATURE, 1997, 388 (6639) :296-300
[8]   Identification of a major co-receptor for primary isolates of HIV-1 [J].
Deng, HK ;
Liu, R ;
Ellmeier, W ;
Choe, S ;
Unutmaz, D ;
Burkhart, M ;
DiMarzio, P ;
Marmon, S ;
Sutton, RE ;
Hill, CM ;
Davis, CB ;
Peiper, SC ;
Schall, TJ ;
Littman, DR ;
Landau, NR .
NATURE, 1996, 381 (6584) :661-666
[9]   Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120 [J].
Derdeyn, CA ;
Decker, JM ;
Sfakianos, JN ;
Wu, XY ;
O'Brien, WA ;
Ratner, L ;
Kappes, JC ;
Shaw, GM ;
Hunter, E .
JOURNAL OF VIROLOGY, 2000, 74 (18) :8358-8367
[10]   AMD310, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor [J].
Donzella, GA ;
Schols, D ;
Lin, SW ;
Esté, JA ;
Nagashima, KA ;
Maddon, PJ ;
Allaway, GP ;
Sakmar, TP ;
Henson, G ;
De Clercq, E ;
Moore, JP .
NATURE MEDICINE, 1998, 4 (01) :72-77